Castle Biosciences, Inc. (CSTL) Profit Margin
Castle Biosciences, Inc. (CSTL) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-12-31 | 6.02% |
| 2020-12-31 | -16.42% |
| 2021-12-31 | -33.26% |
| 2022-12-31 | -48.99% |
| 2023-12-31 | -26.15% |
| 2024-12-31 | 5.49% |
| 2025-12-31 | -7.02% |
How CSTL compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| AMN | AMN Healthcare Services Inc | -3.51% |
| CERS | Cerus Corporation | -6.68% |
| AXGN | Axogen Inc. | -6.97% |
| RMTI | Rockwell Medical Inc. | -7.67% |
| AZTA | Azenta Inc. | -9.39% |
These are five companies in the same sector as CSTL with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Castle Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("CSTL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CSTL | $32.91 | +0.80% | 0.19M |
| 3 | ||||
| 4 | ||||
| 5 |